Latest Articles

Publication Date
Use of Continuous Oral Drospirenone for Menstrual Suppression in Adolescents.

To describe experiences of adolescents taking continuous drospirenone (DRSP-C) oral contraceptives, without placebo, for menstrual suppression, including breakthrough bleeding and other side-effects.

Published: Oct. 10, 2024, midnight
Blocking GATA6 Alleviates Pyroptosis and Inhibits Abdominal Wall Endometriosis Lesion Growth Through Inactivating the PI3K/AKT Pathway.

Endometriosis is a benign gynecological disorder characterized by the abnormal presence of endometrium-like cells, referred to as ectopic tissue, located outside the uterine cavity. Beyond the abnormal proliferation of endometrium-like …

Published: Oct. 4, 2024, midnight
The association between endometrial polyps and insulin resistance from the expression of PI3K and AKT proteins perspective - BioMed Central

The association between endometrial polyps and insulin resistance from the expression of PI3K and AKT proteins perspective BioMed Central

Published: June 22, 2024, 7 a.m.
Serac’s imaging agent marks a breakthrough in endometriosis detection - PharmaTimes

Serac’s imaging agent marks a breakthrough in endometriosis detection PharmaTimes

Published: June 7, 2024, 7 a.m.
FDA grants breakthrough designation for ovarian cancer liquid biopsy - TechTarget

FDA grants breakthrough designation for ovarian cancer liquid biopsy TechTarget

Published: May 31, 2024, 7 a.m.
Joe Biden’s Executive Order on Women’s Health Research Expected to Lead to Breakthroughs for Those with Endometriosis - Endometriosis Foundation of America - The Blossom

Joe Biden’s Executive Order on Women’s Health Research Expected to Lead to Breakthroughs for Those with Endometriosis Endometriosis Foundation of America - The Blossom

Published: March 27, 2024, 7 a.m.
Study reveals breakthrough in non-invasive detection of endometrial cancer - News-Medical.Net

Study reveals breakthrough in non-invasive detection of endometrial cancer News-Medical.Net

Published: March 24, 2024, 7 a.m.
Edap’s Focal One snags FDA breakthrough designation to treat endometriosis - BioWorld Online

Edap’s Focal One snags FDA breakthrough designation to treat endometriosis BioWorld Online

Published: March 7, 2024, 8 a.m.
EDAP obtains FDA breakthrough status for endometriosis device - Medical Device Network

EDAP obtains FDA breakthrough status for endometriosis device Medical Device Network

Published: March 5, 2024, 8 a.m.
EDAP Receives FDA Breakthrough Device Designation For Focal One - MPO-mag

EDAP Receives FDA Breakthrough Device Designation For Focal One MPO-mag

Published: March 5, 2024, 8 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!